Meloxicam in Mohs Micrographic Surgery
Recruiting now · Phase 4
Conditions studied: Postoperative Pain, Acute, Skin Cancer
In brief
The goal of this clinical trial is to explore alternative methods of postoperative pain control in Mohs micrographic surgery. The main aims are: * To provide more information to the Mohs surgery community regarding postoperative pain control. * Reducing pain improves the overall comfort and well-being of patients, leading to a better post-operative experience. * To provide patients with an alternative and potentially superior NSAID for pain control (compared to standard-of-care ibuprofen). Researchers will compare 1) a single of dose Meloxicam 7.5 mg, followed by acetaminophen 500 mg; 2) a single dose of Meloxicam 15 mg, followed by acetaminophen 500 mg; 3) a single dose of acetaminophen 500 mg, followed by alternating ibuprofen 200 mg and acetaminophen 500 mg to see which better moderate pain control and patient satisfaction. Participants will be asked to complete pain and patient satisfaction surveys.
Key facts
- Study ID
- NCT07200544
- Run by
- University of Oklahoma
- People needed
- 300
- Starts
- 2025-10-15
- Expected to finish
- 2026-08-02
- Last updated by the study team
- 2025-12-15
Who can join
Age: 18 and older, up to 110. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All adult patients who consents to the study and are undergoing Mohs micrographic surgery at the University of Oklahoma.
You may not qualify if…
- Women who are pregnant, suspected to be pregnant, or planning to become pregnant during the study period will be excluded from participation.
- Chronic liver disease (chronic hepatitis, acute hepatitis, cirrhosis, NASH, NAFLD, alcoholic liver disease, hemochromatosis, Wilson's disease)
- Chronic kidney disease stage III or greater,
- Aspirin-sensitive asthma
- History of chronic NSAID use
- Patients vulnerable to drug interactions
- GI bleeds
- Peptic ulcers
- Non-English speakers
Where it is running
- University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.